Targeted Genetics Cp (TGEN)

Company Overview
Targeted Genetics Corporation, a clinical-stage biotechnology company, engages in the research and development of gene therapy products and technologies for the treatment of acquired and inherited diseases. Its products include tgAAC94, a Phase I/II trial product for the treatment of inflammatory arthritis and other inflammatory diseases; and tgAAC09, a Phase II clinical product, which is used for the treatment of HIV/AIDS. The company also engages in the development, manufacture, and clinical evaluation of AAV-based therapies with Celladon’s portfolio of genes and cardiovascular expertise for the treatment of congestive heart failure. In addition, Targeted Genetics provides novel ...
read more

QUOTE

As of 12:56PM EDT July 24, 2014
$ N/A   N/A (N/A%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: N/A
52 Week High: N/A Bid (size): N/A
52 Week Low: N/A Ask (size): N/A

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: -
Mailing Address: 1100 OLIVE WAY STE 100 SEATTLE WA 98101 Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612 TARGETED GENETICS C
Phone: 206-623-7612
Fax: 206-223-0288
Website: http://www.targen.com

Company Details:

Symbol: TGEN
SIC: 921114
State location: WA
Sector: -
State of Inc: WA
Employees: 58
Type: NASDAQ

Key executives:

Name Age Position

LATEST ARTICLES

LATEST STOCK PROMOTIONS

Targeted Genetics Cp (TGEN) MESSAGE BOARD

Post # Subject Re Name Date
1 A failure to lead and inspire loyalty in... 0
2 Ran the company into the ground Lawrence,... 0
3 Ran the company into the ground 0
4 Here on this message board we are inviting... 0